Investigational Drug Information for Vesnarinone
✉ Email this page to a colleague
What is the drug development status for Vesnarinone?
Vesnarinone is an investigational drug.
There have been 4 clinical trials for Vesnarinone.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Sarcoma, Kaposi. The leading clinical trial sponsors are Otsuka America Pharmaceutical and [disabled in preview].
Summary for Vesnarinone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,257 |
| WIPO Patent Applications | 2,492 |
| Japanese Patent Applications | 509 |
| Clinical Trial Progress | Phase 2 (1969-12-31) |
| Vendors | 46 |
Recent Clinical Trials for Vesnarinone
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3 | Otsuka America Pharmaceutical | Phase 1 |
| A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons | Otsuka America Pharmaceutical | N/A |
| A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma | Otsuka America Pharmaceutical | Phase 2 |
Clinical Trial Summary for Vesnarinone
Top disease conditions for Vesnarinone
Top clinical trial sponsors for Vesnarinone
US Patents for Vesnarinone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
